Vizual Stocks works best vertically on mobile.
VizualStocks APIOperating KPI and segment definitions available for Medpace Holdings (MEDP) through the VizualStocks API.
Revenue from Medpace's clinical research services for anti-viral and anti-infective trials during the period, reported as AVAI. This therapeutic-area classification includes applicable reimbursed out-of-pocket revenue.
avaiRevenueMedpace's anticipated future revenue from awarded clinical research work that remains incomplete at period end. The series follows the ASC 606 revenue basis from 2018, is affected by cancellations, scope changes and foreign exchange, and is not a guarantee of future revenue.
backlogRevenue from Medpace's clinical research services for cardiology trials during the period. This therapeutic-area classification includes applicable reimbursed out-of-pocket revenue.
cardiologyRevenueRevenue from Medpace's clinical research services for central nervous system trials during the period. Historical values use the issuer's recast therapeutic-area comparisons, including the revised allocation between this category and Other.
centralNervousSystemRevenueRevenue from Medpace's clinical research services for metabolic-disease trials during the period. Values follow the issuer's recast therapeutic-area classification and include applicable reimbursed out-of-pocket revenue.
metabolicRevenueNew clinical research business awarded to Medpace during the period, net of cancellations and modifications to previously awarded work. The series follows the ASC 606 revenue basis from 2018 and measures an award flow rather than the period-end backlog balance.
netNewBusinessAwardsRevenue from Medpace's clinical research services for oncology trials during the period. This is a therapeutic-area revenue disaggregation, including applicable reimbursed out-of-pocket revenue, rather than a separate reportable segment.
oncologyRevenueRevenue from Medpace's clinical research services assigned to therapeutic areas outside Oncology, Metabolic, Central Nervous System, Cardiology and AVAI. The issuer's Other category primarily includes nephrology, rheumatology, musculoskeletal, dermatology, gastroenterology and ophthalmology; historical observations use its recast classifications.
otherRevenue